Oklahoma 2022 2022 Regular Session

Oklahoma House Bill HB3019 Introduced / Bill

Filed 01/13/2022

                     
 
Req. No. 8515 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
STATE OF OKLAHOMA 
 
2nd Session of the 58th Legislature (2022) 
 
HOUSE BILL 3019 	By: Fetgatter 
 
 
 
 
 
AS INTRODUCED 
 
An Act relating to medical marijuana; amending 63 
O.S. 2021, Sections 427.2 and 427.18, which relate to 
the Oklahoma Medical Marijuana and Patient Protection 
Act; modifying and adding definitions; allowing for 
the use of clear containers; directing dispensaries 
to use exit package at point of sale and transfer; 
and providing an effective date . 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     AMENDATORY     63 O.S. 2021, Section 427.2, is 
amended to read as follows: 
Section 427.2 As used in the Oklahoma Medical Marijuana and 
Patient Protection Act : 
1.  "Advertising" means the act of providin g consideration for 
the publication, dissemination, solicitation, or circul ation, of 
visual, oral, or written comm unication to induce directly or 
indirectly any person to patronize a particular medical marijuana 
business, or to purchase particular medical marijuana or a medical 
marijuana product.  Advertising includes marketing, but does not 
include packaging and labe ling; 
2.  "Authority" means the Oklahoma Medical Marijuana Authority;   
 
Req. No. 8515 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
3.  "Batch number" means a unique numeric or alphanumeric 
identifier assigned prior to testing to allow for inventory tracking 
and traceability; 
4. "Cannabinoid" means any of the che mical compounds that are 
active principles of marijuana; 
5.  "Caregiver" means a family member or assistant who regularly 
looks after a medical m arijuana patient license holder whom a 
physician attests needs assistance; 
6.  "Child-resistant" means special packag ing that is: 
a. designed or constructed to be significantly difficult 
for children under five (5) years of age to open and 
not difficult for normal adults to use properly as 
defined by 16 C.F.R. 1700.15 (1995) and 16 C.F.R. 
1700.20 (1995), and 
b. opaque so that the outermost packaging does not allow 
the product to be seen without opening the packaging 
material, and 
c. resealable to maintain i ts child-resistant 
effectiveness for multiple openings for any product 
intended for more than a single use or containi ng 
multiple servings; 
7.  "Clone" means a nonflowering plant cut from a mother plant 
that is capable of devel oping into a new plant and ha s shown no 
signs of flowering;   
 
Req. No. 8515 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
8.  "Commissioner" means the State Commissio ner of Health; 
9.  "Complete application " means a document prepared in 
accordance with the provisions set forth i n the Oklahoma Medical 
Marijuana and Patient Protection Act , rules promulgated pursuant 
thereto, and the forms and instructions provided by the Department, 
including any supporting do cumentation required and the applicable 
license application fee; 
10.  "Department" means the State Department of Health; 
11.  "Director" means the Executive Director of the Oklahoma 
Medical Marijuana Authority; 
12.  "Dispense" means the selling of medical marijuana or a 
medical marijuana product to a qualified patient or the designated 
caregiver of the patient that is packaged in a suitable con tainer 
appropriately labeled for subsequent administration to or use by a 
qualifying patient; 
13.  "Dispensary" means a medical marijuana dispensary, an 
entity that has been licensed by the Department pursuant t o the 
Oklahoma Medical Marijuana and Patient Protection Act to purchase 
medical marijuana or medical marijuana products from a licensed 
medical marijuana commercial grower or licensed medical marijuana 
processor, to prepare and package non infused pre-rolled medical 
marijuana, and to sell medical marijuana or medical marijuana 
products to licensed patients and caregivers as defined in this   
 
Req. No. 8515 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
section, or sell or transfer products to another licensed 
dispensary; 
14.  "Edible medical marijuana product " means any medical-
marijuana-infused product for which t he intended use is oral 
consumption including, but not limited to, any type of food, drink 
or pill; 
15.  "Entity" means an individual, general partnership, limited 
partnership, limited liability company, trust, estate, association, 
corporation, cooperative or any other legal or commercial entity; 
16. "Exit package" means an opaque bag that is provided at the 
point of sale in which pre-packaged medical marijuana is placed; 
17. "Flower" means the reproductive organs of the marijuana or 
cannabis plant referred to as the bud or parts of the plant that are 
harvested and used for consumption in a variety of medical marijuana 
products; 
17. 18. "Flowering" means the reproductive state of the 
marijuana or cannabis plant in which there are physical signs of 
flower or budding out of the nodes of the stem; 
18. 19. "Food-based medical marijuana concentrate" means a 
medical marijuana concentrat e that was produced by extracting 
cannabinoids from medical marijuana through the use of propylene 
glycol, glycerin, butter, olive oil, coconut oil or other typical 
food-safe cooking fats;   
 
Req. No. 8515 	Page 5  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
19. 20. "Harvest batch" means a specifically identified 
quantity of medical marijuana that is uniform in strain, cultivated 
utilizing the same cultivation practices, harvested at the same time 
from the same location and cured under uniform conditions; 
20. 21. "Harvested marijuana" means postflowering medical 
marijuana not including trim, concentrate or waste; 
21. 22. "Heat- or pressure-based medical marijuana concentrate " 
means a medical marijuana concentrate tha t was produced by 
extracting cannabinoids from medical marijuana through the use of 
heat or pressure; 
22. 23. "Immature plant" means a nonflowering marijuana plant 
that has not demonstrated signs of flowering; 
23. 24. "Inventory tracking system" means the required tracking 
system that accounts for the entire life span of medical marijuana 
and medical marijuana products, including any testing samples 
thereof and medical marijuana waste; 
24. 25. "Licensed patient" or "patient" means a person who has 
been issued a medical marijuana patient license by the State 
Department of Health or Oklahoma Medical Marijuana Aut hority; 
25. 26. "Licensed premises" means the premises specified in an 
application for a medical marijuana business license, m edical 
marijuana research facility license or medical marijuana education 
facility license pursuant to the Oklahoma Medical Marij uana and 
Patient Protection Act that are owned or in possession of the   
 
Req. No. 8515 	Page 6  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
licensee and within which the licensee is authorized to cultivate, 
manufacture, distribute, sell, store, transport, test or researc h 
medical marijuana or medical marijuana products in a ccordance with 
the provisions of the Oklahoma Medical Marijuana and Patient 
Protection Act and rules promulgated pursuant there to; 
26. 27. "Manufacture" means the production, propagation, 
compounding or processing of a medical marijuana product, excluding 
marijuana plants, either directly or indirectly by extraction from 
substances of natural or synthetic origin, or independently by means 
of chemical synthesis, or by a combination of extraction and 
chemical synthesis; 
27. 28. "Marijuana" shall have the same meaning as such term is 
defined in Section 2-101 of this title; 
28. 29. "Material change" means any change that woul d affect 
the qualifications for licensure of an applic ant or licensee; 
29. 30. "Mature plant" means a harvestable female marijuana 
plant that is flowering; 
30. 31.  "Medical marijuana business (MMB) " means a licensed 
medical marijuana dispensary, medical marijua na processor, medical 
marijuana commercial grower, medi cal marijuana laboratory, medical 
marijuana business operator or a medical marijuana transporter; 
31. 32. "Medical marijuana concentrate " or "concentrate" means 
a specific subset of medical marijuana that was produced by 
extracting cannabinoids from medical m arijuana.  Categories of   
 
Req. No. 8515 	Page 7  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
medical marijuana concentrate include water -based medical marijuana 
concentrate, food-based medical marijuana concentrate, solvent -based 
medical marijuana concentrate, and heat- or pressure-based medical 
marijuana concentrate; 
32. 33.  "Medical marijuana commercial grower" or "commercial 
grower" means an entity licensed to cultivate, prepare and package 
medical marijuana or package medical marijuana as pre -rolls, and 
transfer or contract for transfer m edical marijuana and medical 
marijuana pre-rolls to a medical marijuana dispensary, medical 
marijuana processor, any other medical marijuana commercial grower, 
medical marijuana research facility or medical marijuana education 
facility.  A commercial grower may sell seeds, flower or clones to 
commercial growers pursuant to the Oklahoma Medical Marijuana a nd 
Patient Protection Act; 
33. 34. "Medical marijuana education facility " or "education 
facility" means a person or entity app roved pursuant to the Oklahoma 
Medical Marijuana and Patient Prote ction Act to operate a facility 
providing training and educatio n to individuals involving the 
cultivation, growing, harvesting, curing, preparing, packaging or 
testing of medical marijuana, or the production, manufacture , 
extraction, processing, packaging or creation of medical-marijuana-
infused products or medical ma rijuana products as described in the 
Oklahoma Medical Marijuana and Patient Protection Act ;   
 
Req. No. 8515 	Page 8  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
34. 35. "Medical-marijuana-infused product" means a product 
infused with medical marijuana including, bu t not limited to, edible 
products, ointments and tinctures; 
35. 36. "Medical marijuana product" or "product" means a 
product that contains cannabinoids that have been extracted from 
plant material or the resin therefrom b y physical or chemical means 
and is intended for administration to a qualified patient includ ing, 
but not limited to, oils, tinctures, edibles, pills, topical forms, 
gels, creams, vapors, patches, liquids , and forms administered by a 
nebulizer, excluding l ive plant forms which are considered m edical 
marijuana; 
36. 37. "Medical marijuana processor " means a person or entity 
licensed pursuant to the Oklahoma Medical Marijuana and Patient 
Protection Act to operate a business including the production, 
manufacture, extraction, processing, packaging o r creation of 
concentrate, medical-marijuana-infused products or medical marijuana 
products as described i n the Oklahoma Medical Marijuana and Patient 
Protection Act; 
37. 38. "Medical marijuana research facility " or "research 
facility" means a person or entity approved pursuant to the Oklahoma 
Medical Marijuana and Patient Protection Act to conduct medical 
marijuana research.  A medical marijuana research facility is not a 
medical marijuana business;   
 
Req. No. 8515 	Page 9  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
38. 39. "Medical marijuana testing laboratory " or "laboratory" 
means a public or private laboratory licensed pursuant to the 
Oklahoma Medical Marijuana and Patient Protection Act to conduct 
testing and research on medical marijuana and medical marijuana 
products; 
39. 40. "Medical marijuana transporter" or "transporter" means 
a person or entity that is licensed p ursuant to the Oklahoma Medical 
Marijuana and Patient Protection Act .  A medical marijuana 
transporter does not include a medic al marijuana business that 
transports its own me dical marijuana, medical ma rijuana concentrate 
or medical marijuana products to a property or facility adjacent to 
or connected to the licensed premises if the property is another 
licensed premises of the sam e medical marijuana business; 
40. 41. "Medical marijuana waste" or "waste" means unused, 
surplus, returned or out-of-date marijuana, plant debris of the 
plant of the genus Cannabis including dead plants and all unused 
plant parts and roots, except the ter m shall not include roots, 
stems, stalks and fan le aves; 
41. 42. "Medical use" means the acquisition, possession, use, 
delivery, transfer or transportation of medical marijuana, medical 
marijuana products, medical marijuana devices or paraphernalia 
relating to the administration of medical marijuana to treat a 
licensed patient;   
 
Req. No. 8515 	Page 10  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
42. 43. "Mother plant" means a marijuana plant that i s grown or 
maintained for the purpose of generating clones, and that will not 
be used to produce plant material for sale to a m edical marijuana 
processor or medical marijuana dispensar y; 
43. 44. "Oklahoma physician" or "physician" means a physician 
licensed by and in good standing with the State Board of Medical 
Licensure and Supervision, the State Board of Osteopathic Examiners 
or the Board of Podiatric Medical Examiners; 
44. 45. "Oklahoma resident" means an individual who can provide 
proof of residency as required by the Oklahoma Medical Marijuana and 
Patient Protection Act ; 
45. 46. "Owner" means, except where the context othe rwise 
requires, a direct beneficial owner including, but not limit ed to, 
all persons or entities as follows: 
a. all shareholders owning an interest of a corporate 
entity and all officers of a corporate entity, 
b. all partners of a general partnership, 
c. all general partners and all limited partners that own 
an interest in a limited partnership, 
d. all members that own an interest in a limited 
liability company, 
e. all beneficiaries that hold a beneficial interest in a 
trust and all trustees of a trust,   
 
Req. No. 8515 	Page 11  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
f. all persons or entities that own interest in a joint 
venture, 
g. all persons or entities that own an interest in a n 
association, 
h. the owners of any other type of legal entity, and 
i. any other person holding an interest or convertible 
note in any entity which owns, operates or manages a 
licensed facility; 
46. 47. "Package" or "packaging" means any container or wrapper 
that may be used by a medical marijuana business to enclose or 
contain medical marijuana ; 
47. 48. "Person" means a natural person, partne rship, 
association, business trust, company, corporation, estat e, limited 
liability company, trust or any other legal enti ty or organization, 
or a manager, agent, owner, director, servant, officer or employee 
thereof, except that "person" does not include any governmental 
organization; 
48. 49. "Pesticide" means any substance or mixture of 
substances intended for preventing, dest roying, repelling or 
mitigating any pest or any substance or mixture of substances 
intended for use as a plant regulator, defolian t or desiccant, 
except that the term "pesticide" shall not include any article that 
is a "new animal drug" as designated by the United States Food and 
Drug Administration;   
 
Req. No. 8515 	Page 12  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
49. 50. "Production batch" means: 
a. any amount of medical marijuana concentrate of the 
same category and produced using the same extraction 
methods, standard operating procedures and an 
identical group of harves t batch of medical marijuana, 
or 
b. any amount of medical marijuana product of the same 
exact type, produced using the same ing redients, 
standard operating procedures and the same production 
batch of medical marijuana concentrate; 
50. 51. "Public institution" means any entity established or 
controlled by the federal government, state government, or a local 
government or municipal ity including, but not limited to, 
institutions of higher education or related research institutions; 
51. 52. "Public money" means any funds or money obtained by the 
holder from any governmental entity including, but not limited to, 
research grants; 
52. 53. "Recommendation" means a document that is signed or 
electronically submitted by a physician on behalf of a patient for 
the use of medical marijuana pursuant to the Oklahoma Medical 
Marijuana and Patient Protection Act ; 
53. 54. "Registered to conduct b usiness" means a person that 
has provided proof that the business applicant or licensee is in 
good standing with the Oklahoma Sec retary of State;   
 
Req. No. 8515 	Page 13  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
54. 55.  "Remediation" means the process by whic h a harvest 
batch or production batch that fails testing undergoes a procedure 
to remedy the harvest batch or production batch and is retested in 
accordance with Oklahoma laws, rules and regu lations; 
55. 56. "Research project" means a discrete scientific endeavor 
to answer a research question or a set of research qu estions related 
to medical marijuana and is required for a medical marijuan a 
research license.  A research project shall include a description of 
a defined protocol, clearly articulated goals, defined methods and 
outputs, and a defined start and end date .  The description shall 
demonstrate that the research project will comply wi th all 
requirements in the Oklahoma Medical Marijuana and Patient 
Protection Act and rules promulgated pursuant thereto .  All research 
and development conducted by a medical marijua na research facility 
shall be conducted in furtherance of an approved resea rch project; 
56. 57. "Revocation" means the final decision by the Department 
that any license issued pursuant t o the Oklahoma Medical Marijuana 
and Patient Protection Act is rescinded because the individual or 
entity does not comply with the applicable re quirements set forth in 
the Oklahoma Medical Marijuana and Patient Protection Act or rules 
promulgated pursuant thereto; 
57. 58. "School" means a public or private elementary , middle 
or high school used for school classes and instruction .  A 
homeschool, daycare or child-care child care facility shall not be   
 
Req. No. 8515 	Page 14  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
considered a "school" as used in the Oklahoma Medical Marijuana and 
Patient Protection Act ; 
58. 59. "Shipping container" means a hard-sided container with 
a lid or other enclosure that can be secured i n place.  A shipping 
container is used solely for the transport of medical m arijuana, 
medical marijuana concentrate, or medical marijuana products between 
medical marijuana business es, a medical marijuana research facility, 
or a medical marijuana education facility; 
59. 60. "Solvent-based medical marijuana c oncentrate" means a 
medical marijuana concentrate that was produced by extracting 
cannabinoids from medical marijuana through t he use of a solvent 
approved by the Department; 
60. 61. "State Question" means Oklahoma State Question No. 788, 
Initiative Petition No. 412, approved by a majority vote of the 
citizens of Oklahoma on June 26, 2018; 
61. 62. "Strain" means the name given to a particular variety 
of medical marijuana that is based on a combination of factors which 
may include, but is n ot limited to, botanical lineage, appe arance, 
chemical profile and accompan ying effects.  An example of a "strain" 
would be "OG Kush" or "Pineapple Express"; 
62. 63. "THC" means tetrahydrocannabinol, which is the prim ary 
psychotropic cannabinoid in marijuana formed by decarboxylation of 
naturally tetrahydrocannabinolic acid, which g enerally occurs by 
exposure to heat;   
 
Req. No. 8515 	Page 15  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
63. 64. "Transporter agent" means a person who transports 
medical marijuana or medical marijuana prod ucts as an employee of a 
licensed medical marijuana business and holds a transporter agent 
license specific to that busin ess pursuant to the Oklahoma Medical 
Marijuana and Patient P rotection Act; 
64. 65. "Universal symbol" means the image established by t he 
State Department of Health or Oklahoma Medic al Marijuana Authority 
and made available to licensees through its website ind icating that 
the medical marijuana or the medical mariju ana product contains THC; 
65. 66. "Usable marijuana" means the dried leave s, flowers, 
oils, vapors, waxes and other portions of the marijuana plant an d 
any mixture or preparation thereof, excludin g seeds, roots, stems, 
stalks and fan leaves; and 
66. 67. "Water-based medical marijuana concentrate " means a 
concentrate that was pr oduced by extracting cannabinoids from 
medical marijuana through the use of only water, ice or dry ice. 
SECTION 2.     AMENDATORY     63 O.S. 2021, Section 427.18, is 
amended to read as follows: 
Section 427.18 A.  An Oklahoma medical mar ijuana business shall 
not sell, transfer or otherwise distribute medical mar ijuana or 
medical marijuana product that has not been packaged and labeled in 
accordance with this sec tion and rules promulgated by the State 
Commissioner of Health.   
 
Req. No. 8515 	Page 16  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
B.  A medical marijuana dispensary shall return medical 
marijuana and medical marijuana pr oduct that does not meet packaging 
or labeling requirements in this section or rules promulgated 
pursuant thereto to the entity who transferred it to the dispensary .  
The medical marijuana dispensary shall document to whom the item wa s 
returned, what was r eturned and the date of the return or dispose of 
any usable marijuana that does not meet these require ments in 
accordance with the Oklahoma Medical Marijuana and Patient 
Protection Act. 
C.  1.  Medical marijuana packaging shall be pac kaged to 
minimize its appeal to children and shall not depict images other 
than the business name logo of the medical mariju ana producer and 
image of the product. 
2.  A medical marijuana business shall not place any content on 
a container in a manner that reasonably appears to target 
individuals under the age of twenty -one (21) including, but not 
limited to, cartoon characters or similar images. 
3.  Labels on a container shall not include any false or 
misleading statements. 
4.  No container shall be intenti onally or knowingly la beled so 
as to cause a reasonable patient confusion as to whether the medical 
marijuana, medical marij uana concentrate or medical marijuana 
product is a trademarked product or labe led in a manner that 
violates any federal trademark la w or regulation.   
 
Req. No. 8515 	Page 17  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
5.  The label on the container shall not make any claims 
regarding health or physical benefits to the patie nt. 
6. All The container itself may be clear in order to allow 
licensed medical marijuana patients and licensed medical marijuana 
caregivers the ability to view the product inside the container but 
shall be child-resistant, as defined in Section 427.2 of this title. 
7. At the point of sale and transfer of any medical marijuana, 
medical marijuana concentrate and, or medical marijuana product s to 
a licensed medical marijuana patient or licensed medical mar ijuana 
caregiver, the dispensary shall be in a child-resistant container at 
the point of transfer to the patient or caregiver place the medical 
marijuana, medical marijuana concentrate , or medical marijuana 
products in an exit package, as such term is defined in Section 
427.2 of this title. 
D.  The State Department of Health shall develop minimum 
standards for packaging and labeling of medical marijuana, medical 
marijuana concentrate, and medical marijuana products .  Such 
standards shall include, but not be limited to, the required 
contents of labels to be affi xed to all medical marijuana , medical 
marijuana concentrate, and medical marijuana products prior to 
transfer to a licensed patient or caregiver, which shall include, at 
a minimum: 
1.  THC and other cannabinoid potency, and terpenoid potency;   
 
Req. No. 8515 	Page 18  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
2. A statement indicating that the product has been tested for 
contaminants; 
3. One or more product warnings to be determined by the 
Department; and 
4. Any other information the Department deems necessar y. 
SECTION 3.  This act shall become effective November 1, 2022. 
 
58-2-8515 GRS 12/27/21